QNCX

NASD Quince Therapeutics, Inc.
Oct 8, 2026 · 1:23 AM ET EOD Market Closed

$26.72 ↑ +0.00 (+0.00%) Trading Up from the previous close of $26.72, $1.23 below the day’s high of $27.95

YTD change
-96.01%
vs 20-day SMA
-9.33%
vs 200-day SMA
-75.50%

Price ranges

Previous day
$26.81 $28.15
open $27.68 close $26.81
-$0.87 (-3.14%)
Today
$26.72 $27.95
open $26.74 now $26.72
-$0.02 (-0.07%)
Past week
$26.81 $32.59
from $31.17 now $26.72
-$4.45 (-14.28%)
Past month
$25.78 $32.99
from $29.50 now $26.72
-$2.78 (-9.42%)
This year
$0.08 $670.00
from $670.00 now $26.72
-$643.28 (-96.01%)

Price & Performance

+26.56 (+16292.64%) / 6M

$-2.6320$10.69$24.01$37.33Apr 7Jul 8Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.1% away from all-time highs of $909.98
  • QNCX is down 96% since the beginning of the year
  • QNCX is down 92% over the past 12 months
  • QNCX is down 9% over the past 1 month
  • 5% of all QNCX investors are betting against QNCX

QNCX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +1401.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-12.31
Earnings momentum -724.0% Quarterly EPS growth
Quarterly change -724.0%

Valuation

P/E ratio 0.19
Enterprise value $192.3M
Beta 0.90

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$116.0M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $27.3M

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $413.08 +2.60%
MRNA Moderna, Inc. $196.48 +4.81%
RVMD Revolution Medicines, Inc. $200.87 +0.50%
ROIV Roivant Sciences Ltd. $34.75 -2.20%
BNTX BioNTech SE Sponsored ADR $95.25 -0.50%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.